Biogen Is Building a COVID-19 Biobank With the Broad Institute
One of the world's largest biotechnology companies is making the best of a bad situation with a little help from its neighbors. In partnership with the Broad Institute of MIT and Harvard, Biogen (NASDAQ: BIIB) has formed a consortium that will build and share a COVID-19 biobank.
In early March, an executive from Biogen didn't realize they were COVID-19 positive while shaking hands with colleagues at the company's annual leadership meeting. Now, the cluster of cases that led to means there are a lot of Biogen employees in Massachusetts who were infected with the coronavirus and have had sufficient time to recover.
Image source: Getty Images.
Source Fool.com
